Hedgehog pathway inhibitor (original) (raw)
Hedgehog pathway inhibitors, also sometimes called hedgehog inhibitors, are small molecules that inhibit the activity of a component of the Hedgehog signaling pathway. Due to the role of aberrant Hedgehog signaling in tumor progression and cancer stem cell maintenance across cancer types, inhibition of the Hedgehog signaling pathway can be a useful strategy for restricting tumor growth and for preventing the recurrence of the disease post-surgery, post-radiotherapy, or post-chemotherapy. Thus, Hedgehog pathway inhibitors are an important class of anti-cancer drugs.At least three Hedgehog pathway inhibitors have been approved by the Food and Drug Administration (FDA) for cancer treatment. These include vismodegib and sonidegib, both inhibitors of Smoothened (SMO), which are being used for t
| Property | Value |
|---|---|
| dbo:abstract | Hedgehog pathway inhibitors, also sometimes called hedgehog inhibitors, are small molecules that inhibit the activity of a component of the Hedgehog signaling pathway. Due to the role of aberrant Hedgehog signaling in tumor progression and cancer stem cell maintenance across cancer types, inhibition of the Hedgehog signaling pathway can be a useful strategy for restricting tumor growth and for preventing the recurrence of the disease post-surgery, post-radiotherapy, or post-chemotherapy. Thus, Hedgehog pathway inhibitors are an important class of anti-cancer drugs.At least three Hedgehog pathway inhibitors have been approved by the Food and Drug Administration (FDA) for cancer treatment. These include vismodegib and sonidegib, both inhibitors of Smoothened (SMO), which are being used for the treatment of basal cell carcinoma. Arsenic trioxide, an inhibitor of GLI transcription factors, is being used for the treatment of acute promyelocytic leukemia. In addition, multiple other Hedgehog pathway inhibitors are in different phases of clinical trials. (en) |
| dbo:wikiPageID | 52923676 (xsd:integer) |
| dbo:wikiPageLength | 25890 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1079259270 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Cancer dbr:Bcl-2 dbr:Saridegib dbr:Breast_cancer dbr:Antagonist dbr:Hoffmann-La_Roche dbr:Pfizer dbr:Renal_cell_carcinoma dbr:Rhabdomyosarcoma dbr:DNA dbr:Vismodegib dbr:Cancer_stem_cells dbr:P53 dbr:Medulloblastoma dbr:Meningioma dbr:Oncogenes dbr:Eli_Lilly_and_Company dbr:Enzyme dbr:Genentech dbr:Genes dbr:Glasdegib dbr:Glioblastoma dbr:Glioma dbr:Glycoproteins dbr:Monoclonal_antibody dbr:Myc dbr:Apoptosis dbr:Malignant dbr:Stem_cells dbr:Basal_cell_carcinoma dbr:Pancreatic_cancer dbr:Prostate_cancer dbr:Bristol-Myers_Squibb dbr:Transcription_factors dbr:Tumor dbr:Catalyzes dbr:Acute_myeloid_leukemia dbr:Acute_promyelocytic_leukemia dbr:Food_and_Drug_Administration dbr:Angiogenesis dbr:Novartis dbr:Osteosarcoma dbr:Cell_division dbr:Cell_nucleus dbc:Hedgehog_signaling_pathway dbr:Gorlin_syndrome dbr:Epithelial-mesenchymal_transition dbr:Hedgehog_signaling_pathway dbr:Chemotherapy dbr:KRAS dbr:Homeobox_protein_NANOG dbr:Autocrine_signaling dbr:Sonidegib dbr:Mesothelioma dbr:Metastasis dbr:National_Cancer_Institute dbr:Neuroblastoma dbr:Cancer_stem_cell dbr:Radiotherapy dbr:Smoothened dbr:Palmitoylation dbr:Ovarian_cancer dbr:Paracrine_signaling dbr:SOX2 dbr:Colon_cancer dbr:Autosomal_dominant_disorder dbr:Chronic_myeloid_leukemia dbr:Curis dbr:Small_cell_lung_cancer dbr:Chemotherapies dbr:Exelexis dbr:Rhabdosarcoma dbr:Taladegib |
| dbp:wikiPageUsesTemplate | dbt:Reflist dbt:Short_description |
| dcterms:subject | dbc:Hedgehog_signaling_pathway |
| rdfs:comment | Hedgehog pathway inhibitors, also sometimes called hedgehog inhibitors, are small molecules that inhibit the activity of a component of the Hedgehog signaling pathway. Due to the role of aberrant Hedgehog signaling in tumor progression and cancer stem cell maintenance across cancer types, inhibition of the Hedgehog signaling pathway can be a useful strategy for restricting tumor growth and for preventing the recurrence of the disease post-surgery, post-radiotherapy, or post-chemotherapy. Thus, Hedgehog pathway inhibitors are an important class of anti-cancer drugs.At least three Hedgehog pathway inhibitors have been approved by the Food and Drug Administration (FDA) for cancer treatment. These include vismodegib and sonidegib, both inhibitors of Smoothened (SMO), which are being used for t (en) |
| rdfs:label | Hedgehog pathway inhibitor (en) |
| owl:sameAs | wikidata:Hedgehog pathway inhibitor https://global.dbpedia.org/id/2eBNn |
| prov:wasDerivedFrom | wikipedia-en:Hedgehog_pathway_inhibitor?oldid=1079259270&ns=0 |
| foaf:isPrimaryTopicOf | wikipedia-en:Hedgehog_pathway_inhibitor |
| is dbo:wikiPageRedirects of | dbr:Hedgehog_pathway_inhibitors |
| is dbo:wikiPageWikiLink of | dbr:Hedgehog_pathway_inhibitors |
| is foaf:primaryTopic of | wikipedia-en:Hedgehog_pathway_inhibitor |